+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Hemodynamic Abnormalities in the Left Atrial Appendage in Patients with Paroxysmal Atrial Fibrillation, with Special Reference to Albumin-Contrast Echocardiographic Aspects

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Aim: We assessed the prolonged dysfunction of the left atrial appendage caused by paroxysmal atrial fibrillation. Methods and Results: Transesophageal echocardiography with intravenous albumin-microspheres (Albunex, 0.2 ml/kg) was performed in 100 consecutive patients (44 patients in sinus rhythm without previous paroxysmal atrial fibrillation: 13 patients in sinus rhythm who had had previous episodes of paroxysmal atrial fibrillation; and 43 patients with sustained atrial fibrillation). We compared the left atrial appendage ejection fraction and degree of opacification in the left atrial appendage with Albunex in the groups. Patients with previous paroxysmal atrial fibrillation had lower left atrial appendage ejection fractions than patients in sinus rhythm without paroxysmal atrial fibrillation (33 ± 14 vs. 47 ± 14%, p < 0.001). More than half of the patients (7/13 [54%]) with previous paroxysmal atrial fibrillation showed delayed and incomplete opacification of the left atrial appendage with Albunex. Conclusion: We conclude that paroxysmal atrial fibrillation causes left atrial appendage stunning, at least in some patients.

          Related collections

          Author and article information

          S. Karger AG
          February 2000
          07 March 2000
          : 92
          : 2
          : 135-143
          Department of Internal Medicine, Fukui Kosei Hospital, Fukui, Japan
          6961 Cardiology 1999;92:135–143
          © 2000 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Figures: 3, Tables: 3, References: 27, Pages: 9
          Noninvasive and Diagnostic Cardiology


          Comment on this article